Devonian Health Group, Inc. (TSE:GSD) has released an update.
Devonian Health Group Inc., a clinical stage botanical pharmaceutical company, has issued stock options to its officers at an exercise price of $0.16, valid for 10 years. The company specializes in developing plant-based drugs and cosmeceuticals targeting inflammatory autoimmune diseases and owns a fully traceable extraction facility in Quebec.
For further insights into TSE:GSD stock, check out TipRanks’ Stock Analysis page.
